Bone tissue regeneration scaffold (null)

Molecular Classification

Device/Biomaterial, polymeric, ceramic, composite, metallic scaffolds

Other Names

Bone scaffold, Bone tissue engineering scaffold, Osteoregenerative scaffold

Disease Roles

Bone defects (trauma, degenerative disease, congenital defects)Orthopedic conditions requiring bone regenerationOsteomyelitis and infection-related bone loss (when loaded with antimicrobial agents)

Bone tissue regeneration scaffold Overview

Bone tissue regeneration scaffolds are three-dimensional biomaterials specifically engineered to provide structural support and biochemical cues that facilitate the regeneration of bone tissue after injury or disease[1][2][3][4][5][6]. These scaffolds may consist of polymers, ceramics, composites, or metals, and can be functionalized with biological molecules such as growth factors, microRNAs, or antibiotics. They serve to mimic the extracellular matrix, promoting the adhesion, differentiation, and proliferation of cells—including osteoblasts and endothelial cells—and may also release drugs or bioactive signals to further accelerate bone healing and prevent infection[1][2][4][5]. Although not considered a classic drug target, they represent a key technology in regenerative medicine and orthopedic surgery.

Mechanism of Action

Controlled drug release (antibiotics, growth factors) Induction of osteogenesis (promotes differentiation of cells into osteoblasts and bone-forming cells) Angiogenesis facilitation (supports vascularization of regenerating tissue) Modulation of immune microenvironment (encourages M2 macrophage polarization for tissue repair) Provides a biodegradable/bioactive substrate for bone cell attachment and proliferation

Biological Functions

Structural support for bone tissue regeneration

Promotes cell adhesion, migration, proliferation, and differentiation

Delivery of biochemical cues such as growth factors, microRNAs, and antibiotics

Mimics extracellular matrix

Facilitates angiogenesis and osteogenesis

Modulates immune responses (e.g., M2 macrophage polarization)

Disease Associations

Bone defects (trauma, degenerative disease, congenital defects)

Orthopedic conditions requiring bone regeneration

Osteomyelitis and infection-related bone loss (when loaded with antimicrobial agents)

Other conditions requiring osseous tissue engineering

Safety Considerations

Immunogenicity (risk of triggering undesired immune response if using certain natural biomaterials)
Toxicity (from loaded drugs or scaffold materials)
Antibiotic resistance (risk associated with antimicrobial scaffolds)
Mechanical failure, inadequate degradation rate, and insufficient vascularization
Infection risk if used as implants

Interacting Drugs

Minocycline

rifampicin

doxycycline

berberine

chlorhexidine

Bone morphogenic protein (BMP)

transforming growth factor-beta (TGF-β)

fibroblast growth factor (FGF)

platelet-derived growth factor (PDGF)

insulin-like growth factor (IGF)

epidermal growth factor (EGF)

MicroRNA mimics/inhibitors

Associated Biomarkers

Biomarker
None specific; generally, efficacy may be monitored by bone formation markers (e.g., alkaline phosphatase, osteocalcin)
angiogenesis markers
infection markers (if antimicrobial functionality present)